A broader evaluation of metabolic outcomes including insulin resistance, adipokines, and inflammatory markers such as C‐reactive protein (CRP) and interleukin‐6 (IL‐6) would provide a more comprehensive understanding of its systemic effects. This evidence concerns the gene IL6 and Insulin resistance.